We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Amdocs
DOX
$5.53B
| $19M | 0.14% |
328,425
+242,622
| +283% | +$14.3M |
|
|
RAD
177
DELISTED
Rite Aid Corporation
RAD
| $18.6M | 0.13% |
121,095
-42,530
| -26% | -$6.35M |
|
178
Expedia Group
EXPE
$31.2B
| $18.2M | 0.13% |
156,172
-131,159
| -46% | -$14.8M |
|
179
Mettler-Toledo International
MTD
$26.8B
| $17.8M | 0.13% |
42,446
+34,124
| +410% | +$13.5M |
|
|
VWR
180
DELISTED
VWR Corporation
VWR
| $17.8M | 0.13% |
628,250
+506,585
| +416% | +$14.7M |
|
|
AVXS
181
DELISTED
AveXis, Inc. Common Stock
AVXS
| $17.7M | 0.13% |
+429,572
| New | +$16.3M |
|
182
Sysco
SYY
$39.7B
| $17.4M | 0.12% |
354,484
+238,744
| +206% | +$12.3M |
|
183
Celanese
CE
$5.09B
| $17.3M | 0.12% |
260,474
+97,094
| +59% | +$6.35M |
|
184
Marriott International
MAR
$98.7B
| $17.3M | 0.12% |
257,484
+243,400
| +1,728% | +$17.2M |
|
|
ALDR
185
DELISTED
Alder Biopharmaceuticals
ALDR
| $17.2M | 0.12% |
526,142
-418,317
| -44% | -$12.7M |
|
186
Trip.com Group
TCOM
$27.5B
| $17.2M | 0.12% |
369,626
-33,480
| -8% | -$1.49M |
|
|
HOLX
187
DELISTED
Hologic
HOLX
| $16.9M | 0.12% |
434,402
-91,597
| -17% | -$3.46M |
|
|
SONC
188
DELISTED
Sonic Corp
SONC
| $16.9M | 0.12% |
643,785
+548,940
| +579% | +$15.1M |
|
189
Cognizant
CTSH
$21.5B
| $16.6M | 0.12% |
348,303
+339,334
| +3,783% | +$19.3M |
|
|
OA
190
DELISTED
Orbital ATK, Inc.
OA
| $16.5M | 0.12% |
+216,829
| New | +$17.3M |
|
191
Devon Energy
DVN
$51.9B
| $16.4M | 0.12% |
+371,431
| New | +$15.1M |
|
192
Adeia
ADEA
$2.86B
| $16.3M | 0.12% |
1,607,211
-682,135
| -30% | -$5.99M |
|
193
Teck Resources
TECK
$29.5B
| $16.3M | 0.12% |
+902,262
| New | +$14.4M |
|
|
FISV
194
Fiserv Inc
FISV
$27.2B
| $16.1M | 0.11% |
324,510
-269,312
| -45% | -$14.1M |
|
195
Biogen
BIIB
$29.9B
| $16.1M | 0.11% |
51,534
-140,007
| -73% | -$41.5M |
|
|
CVT
196
DELISTED
CVENT, INC.
CVT
| $16M | 0.11% |
505,948
+496,468
| +5,237% | +$16.2M |
|
197
Colgate-Palmolive
CL
$72.6B
| $16M | 0.11% |
215,288
+62,974
| +41% | +$4.66M |
|
198
TJX Companies
TJX
$170B
| $15.9M | 0.11% |
424,046
+235,530
| +125% | +$9.22M |
|
199
Hormel Foods
HRL
$13.9B
| $15.7M | 0.11% |
414,945
+241,737
| +140% | +$8.98M |
|
200
Equifax
EFX
$20.3B
| $15.7M | 0.11% |
116,828
+49,048
| +72% | +$6.5M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.